INDIANAPOLIS–(HSMN NewsFeed)–Positron Corporation (OTCBB:POSC ) a molecular imaging solutions company focused on Nuclear Cardiology, predicts a significant rise in demand for Cardiac PET in 2010 with a proposed cut in SPECT reimbursement of 46% and an in…
Devices, Radiology, Cardiology
Positron Corp, Positron Emission Tomography

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Positron Anticipates Cardiac PET Demand to Increase Due to Expanding Reimbursment Differential Between PET and SPECT Imaging”
Leave a Comment